• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一站式介入治疗四联主动脉瓣合并严重冠状动脉疾病：病例报告。

"One-stop" interventional therapy for quadricuspid aortic valve combined with severe coronary artery disease: a case report.

机构信息

Cardiovascular Surgery Ward, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

出版信息

J Cardiothorac Surg. 2024 Sep 12;19(1):526. doi: 10.1186/s13019-024-02985-4.

DOI:10.1186/s13019-024-02985-4
PMID:39261924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11391761/
Abstract

Congenital Quadricuspid Aortic Valve (QAV) malformation is a relatively rare cardiac valve malformation, especially with abnormal coronary opening and severe stenosis of Coronary Artery Disease (CAD). The patient underwent "one-stop" interventional treatment with transcatheter aortic valve replacement and percutaneous coronary stent implantation. Follow up for 12-month with good outcomes.

摘要

先天性四叶式主动脉瓣（QAV）畸形是一种相对罕见的心脏瓣膜畸形，特别是伴有异常冠状动脉开口和严重冠状动脉疾病（CAD）狭窄的患者。该患者接受了经导管主动脉瓣置换术和经皮冠状动脉支架植入术的“一站式”介入治疗。随访 12 个月，结果良好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f33/11391761/5c8b03341758/13019_2024_2985_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f33/11391761/a76be5540db5/13019_2024_2985_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f33/11391761/fe3c262c0403/13019_2024_2985_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f33/11391761/5c8b03341758/13019_2024_2985_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f33/11391761/a76be5540db5/13019_2024_2985_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f33/11391761/fe3c262c0403/13019_2024_2985_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f33/11391761/5c8b03341758/13019_2024_2985_Fig3_HTML.jpg

相似文献

1
"One-stop" interventional therapy for quadricuspid aortic valve combined with severe coronary artery disease: a case report.一站式介入治疗四联主动脉瓣合并严重冠状动脉疾病：病例报告。
J Cardiothorac Surg. 2024 Sep 12;19(1):526. doi: 10.1186/s13019-024-02985-4.
2
A four-leaf clover: A case report of quadricuspid aortic valve stenosis.四叶式主动脉瓣：四叶式主动脉瓣狭窄病例报告
J Card Surg. 2020 May;35(5):1125-1128. doi: 10.1111/jocs.14511. Epub 2020 Mar 12.
3
Concomitant percutaneous coronary intervention and transcatheter aortic valve replacement: safe and feasible replacement alternative approaches in high-risk patients with severe aortic stenosis and coronary artery disease.同期经皮冠状动脉介入治疗与经导管主动脉瓣置换术：重度主动脉瓣狭窄合并冠状动脉疾病高危患者安全可行的替代置换方法。
J Card Surg. 2013 Sep;28(5):481-3. doi: 10.1111/jocs.12176. Epub 2013 Jul 21.
4
Coronary revascularization during treatment of severe aortic stenosis: A meta-analysis of the complete percutaneous approach (PCI plus TAVR) versus the complete surgical approach (CABG plus SAVR).重度主动脉瓣狭窄治疗期间的冠状动脉血运重建：完全经皮入路（PCI加TAVR）与完全手术入路（CABG加SAVR）的荟萃分析
J Card Surg. 2020 Aug;35(8):2009-2016. doi: 10.1111/jocs.14814. Epub 2020 Jul 15.
5
Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach†.经导管主动脉瓣植入术联合择期冠状动脉支架置入术：一种同步治疗方法†
Eur J Cardiothorac Surg. 2015 Jun;47(6):1083-9. doi: 10.1093/ejcts/ezu339. Epub 2014 Sep 12.
6
Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.经导管主动脉瓣置换术与左主干支架置入术患者的预后：TAVR-LM注册研究
J Am Coll Cardiol. 2016 Mar 1;67(8):951-960. doi: 10.1016/j.jacc.2015.10.103.
7
Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience.经皮冠状动脉介入治疗未保护的左主干使用 Impella 心室辅助装置在经导管主动脉瓣植入术前：单中心经验。
J Invasive Cardiol. 2022 Mar;34(3):E196-E201. doi: 10.25270/jic/21.00123. Epub 2022 Jan 20.
8
TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and multivessel or advanced coronary disease: The transcatheter valve and vessels trial (TCW trial): Design and rationale.经导管主动脉瓣植入术与血流储备分数引导的经皮冠状动脉介入治疗对比传统外科主动脉瓣置换术和冠状动脉搭桥术治疗主动脉瓣狭窄合并多支血管病变或晚期冠状动脉疾病患者：经导管瓣膜与血管试验（TCW试验）：设计与原理
Am Heart J. 2024 Apr;270:86-94. doi: 10.1016/j.ahj.2024.01.010. Epub 2024 Feb 1.
9
Transcatheter aortic valve replacement in a patient with quadricuspid aortic valve stenosis and regurgitation.经导管主动脉瓣置换术治疗四叶式主动脉瓣狭窄伴反流患者。
J Invasive Cardiol. 2024 Aug;36(8). doi: 10.25270/jic/24.00076.
10
Complete transcatheter versus surgical approach to aortic stenosis with coronary artery disease: A systematic review and meta-analysis.经导管与外科手术治疗合并冠状动脉疾病的主动脉瓣狭窄：系统评价和荟萃分析。
J Thorac Cardiovasc Surg. 2024 Apr;167(4):1305-1313.e9. doi: 10.1016/j.jtcvs.2022.08.006. Epub 2022 Aug 18.

本文引用的文献

1
Aortic Valve Disease and Associated Complex CAD: The Interventional Approach.主动脉瓣疾病与相关复杂性冠状动脉疾病：介入治疗方法
J Clin Med. 2021 Mar 1;10(5):946. doi: 10.3390/jcm10050946.
2
Timing and Outcomes of Percutaneous Coronary Intervention in Patients Who Underwent Transcatheter Aortic Valve Implantation.接受经导管主动脉瓣植入术患者的经皮冠状动脉介入治疗的时机和结果
Am J Cardiol. 2020 May 1;125(9):1361-1368. doi: 10.1016/j.amjcard.2020.01.043. Epub 2020 Feb 8.
3
Transcatheter aortic valve implantation using Evolut R in quadricuspid aortic valve with severe stenosis and regurgitation.
Cardiovasc Interv Ther. 2019 Jul;34(3):285-287. doi: 10.1007/s12928-018-0544-7. Epub 2018 Aug 25.
4
Quadricuspid Aortic Valve Stenosis: Expanding Our Experience in Transcatheter Aortic Valve Implantation.四叶式主动脉瓣狭窄：拓展我们经导管主动脉瓣植入术的经验
J Invasive Cardiol. 2018 Mar;30(3):E27.
5
Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.经导管主动脉瓣置换术后退行性生物瓣外科瓣的冠状动脉阻塞发生率、预测因素及临床结局：来自 VIVID 登记研究的结果。
Eur Heart J. 2018 Feb 21;39(8):687-695. doi: 10.1093/eurheartj/ehx455.
6
2017 ESC/EACTS Guidelines for the management of valvular heart disease.2017年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2017 Sep 21;38(36):2739-2791. doi: 10.1093/eurheartj/ehx391.
7
Quadricuspid Aortic Valve: A Comprehensive Review.四叶式主动脉瓣：全面综述
Braz J Cardiovasc Surg. 2016 Nov-Dec;31(6):454-460. doi: 10.5935/1678-9741.20160090.
8
Quadricuspid Aortic Valve: Characteristics, Associated Structural Cardiovascular Abnormalities, and Clinical Outcomes.四叶式主动脉瓣：特征、相关结构性心血管异常及临床转归。
Circulation. 2016 Jan 19;133(3):312-9. doi: 10.1161/CIRCULATIONAHA.115.017743. Epub 2015 Dec 3.
9
Outcomes after repair or replacement of dysfunctional quadricuspid aortic valve.功能性四叶式主动脉瓣修复或置换术后的结果。
J Thorac Cardiovasc Surg. 2015 Jul;150(1):79-82. doi: 10.1016/j.jtcvs.2015.03.019. Epub 2015 Mar 19.
10
Repair of quadricuspid aortic valve by bicuspidization: a novel technique.通过双瓣化修复四叶式主动脉瓣：一种新技术。
Interact Cardiovasc Thorac Surg. 2010 Sep;11(3):348-50. doi: 10.1510/icvts.2010.237404. Epub 2010 Jun 23.